Skip to content
10-Q

Quarterly Report

RESMED INC RMD RSMDF

0000943819-26-000025

← back to feed
Filed
May 1, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2026 · Apr 27, 2026 145.06M sh
Shares Diluted Q3 2026 · Mar 31, 2026 145.72M sh
Shares Diluted Q3 2026 · Mar 31, 2026 146.37M sh
Shares Diluted Q3 2026 · Mar 31, 2025 147.22M sh
Shares Diluted Q3 2026 · Mar 31, 2025 147.43M sh
Stock Repurchased Q3 2026 · Mar 31, 2026 $500.04M
Stock Repurchased Q3 2026 · Mar 31, 2025 $200.02M
Dividends Paid Q3 2026 · Mar 31, 2026 $262.57M
Dividends Paid Q3 2026 · Mar 31, 2025 $233.29M
Capex Q3 2026 · Mar 31, 2026 $105.16M
Capex Q3 2026 · Mar 31, 2025 $59.28M
Operating Cash Flow Q3 2026 · Mar 31, 2026 $1.35B
Operating Cash Flow Q3 2026 · Mar 31, 2025 $1.21B
Short Term Debt Q3 2026 · Mar 31, 2026 $259.93M
Short Term Debt Q3 2026 · Jun 30, 2025 $9.9M
Cash And Equivalents Q3 2026 · Mar 31, 2026 $1.66B
Cash And Equivalents Q3 2026 · Jun 30, 2025 $1.21B
Stockholders Equity Q3 2026 · Mar 31, 2026 $6.49B
Stockholders Equity Q3 2026 · Dec 31, 2025 $6.32B
Stockholders Equity Q3 2026 · Sep 30, 2025 $6.12B
Stockholders Equity Q3 2026 · Jun 30, 2025 $5.97B
Stockholders Equity Q3 2026 · Mar 31, 2025 $5.55B
Stockholders Equity Q3 2026 · Dec 31, 2024 $5.25B
Stockholders Equity Q3 2026 · Sep 30, 2024 $5.2B
Stockholders Equity Q3 2026 · Jun 30, 2024 $4.86B
Current Liabilities Q3 2026 · Mar 31, 2026 $1.35B
Current Liabilities Q3 2026 · Jun 30, 2025 $1.02B
Total Liabilities Q3 2026 · Mar 31, 2026 $2.29B
Total Liabilities Q3 2026 · Jun 30, 2025 $2.21B
Current Assets Q3 2026 · Mar 31, 2026 $4.06B
Current Assets Q3 2026 · Jun 30, 2025 $3.51B
Total Assets Q3 2026 · Mar 31, 2026 $8.78B
Total Assets Q3 2026 · Jun 30, 2025 $8.17B
Eps Diluted Q3 2026 · Mar 31, 2026 $2.74
Eps Diluted Q3 2026 · Mar 31, 2026 $7.79
Eps Diluted Q3 2026 · Mar 31, 2025 $2.48
Eps Diluted Q3 2026 · Mar 31, 2025 $6.93
Eps Basic Q3 2026 · Mar 31, 2026 $2.74
Eps Basic Q3 2026 · Mar 31, 2026 $7.82
Eps Basic Q3 2026 · Mar 31, 2025 $2.49
Eps Basic Q3 2026 · Mar 31, 2025 $6.96
Sga Expense Q3 2026 · Mar 31, 2026 $285.66M
Sga Expense Q3 2026 · Mar 31, 2026 $823.25M
Sga Expense Q3 2026 · Mar 31, 2025 $245.3M
Sga Expense Q3 2026 · Mar 31, 2025 $725.89M
Rd Expense Q3 2026 · Mar 31, 2026 $94.27M
Rd Expense Q3 2026 · Mar 31, 2026 $272.56M
Rd Expense Q3 2026 · Mar 31, 2025 $83.94M
Rd Expense Q3 2026 · Mar 31, 2025 $244.84M
Net Income Q3 2026 · Mar 31, 2026 $398.73M
Net Income Q3 2026 · Mar 31, 2026 $1.14B
Net Income Q3 2026 · Dec 31, 2025 $392.59M
Net Income Q3 2026 · Sep 30, 2025 $348.54M
Net Income Q3 2026 · Mar 31, 2025 $365.04M
Net Income Q3 2026 · Mar 31, 2025 $1.02B
Net Income Q3 2026 · Dec 31, 2024 $344.62M
Net Income Q3 2026 · Sep 30, 2024 $311.36M
Operating Income Q3 2026 · Mar 31, 2026 $499.81M
Operating Income Q3 2026 · Mar 31, 2026 $1.44B
Operating Income Q3 2026 · Mar 31, 2025 $426.27M
Operating Income Q3 2026 · Mar 31, 2025 $1.23B
Gross Profit Q3 2026 · Mar 31, 2026 $890.98M
Gross Profit Q3 2026 · Mar 31, 2026 $2.59B
Gross Profit Q3 2026 · Mar 31, 2025 $766.41M
Gross Profit Q3 2026 · Mar 31, 2025 $2.23B
Cost Of Revenue Q3 2026 · Mar 31, 2026 $540.43M
Cost Of Revenue Q3 2026 · Mar 31, 2026 $1.6B
Cost Of Revenue Q3 2026 · Mar 31, 2025 $525.33M
Cost Of Revenue Q3 2026 · Mar 31, 2025 $1.56B
Revenue Q3 2026 · Mar 31, 2026 $1.43B
Revenue Q3 2026 · Mar 31, 2026 $4.19B
Revenue Q3 2026 · Mar 31, 2025 $1.29B
Revenue Q3 2026 · Mar 31, 2025 $3.8B